| Name | Title | Contact Details |
|---|
ACS Media is a Anchorage, AK-based company in the Business Services sector.
Synapse Health is dedicated to improving the Durable Medical Equipment (DME) industry through innovative solutions. Their mission focuses on enhancing experience, accountability, and transparency within the DME ecosystem. By leveraging technology, Synapse Health aims to create seamless experiences for both patients and healthcare providers, addressing long-standing challenges in the industry. The company offers solutions that enhance treatments for chronic and complex diseases by creating, customizing, and digitizing clinical pathways while coordinating care. Their tech-enabled solutions are designed to streamline the DME process, ensuring patients receive the necessary equipment efficiently. Synapse Health serves a range of stakeholders in the healthcare sector, including patients, prescribers, providers, and payors, fostering partnerships to deliver impactful experiences. Synapse Health operates under core values summarized by the acronym E.P.I.C., which stands for Experience, Partnership, Integrity, and Change. Their culture emphasizes collaboration, innovation, and accountability, creating a dynamic environment for individuals committed to transforming the DME industry.
FarmWise builds adaptive robots to farm every single plant for greater yield, better farmer’s profits and a healthier environment.
Buying luxury homes in Arizona is one of the best upscale real estate investments you could make. Discover what Platinum Living Realty has to offer here.
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biologys complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultimas revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.